Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Amicus’ Galafold receives TGA approval for Fabry disease treatment in Australia

pharmaceutical-technologyAugust 17, 2017

Tag: Fabry disease , TGA , Amicus Therapeutics

PharmaSources Customer Service